Virpax Announces Pricing Of $2.25M Public Offering
Portfolio Pulse from Benzinga Newsdesk
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) announced the pricing of a public offering of 1,666,667 shares of common stock and warrants, aiming to raise approximately $2.25 million. The offering includes Series A-1 and A-2 common warrants, both exercisable immediately at $1.35 per share.
May 15, 2024 | 12:22 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Virpax Pharmaceuticals announced a $2.25 million public offering, including shares and warrants priced at $1.35 each. This move aims to raise capital for the company's ongoing projects.
The public offering will dilute existing shares, which typically leads to a short-term decrease in stock price. However, the raised capital could be beneficial for long-term projects.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100